Table 1.
Clinical and pathological characteristic of the participants.
| Characteristic | PTC | Control (healthy subjects) |
|---|---|---|
| Patient number | 80 | 80 |
| Gender | ||
| Male | 18 | 48 |
| Female | 62 | 32 |
| Age (Mean ± SD; year) | 41.63 ± 11.213 | 43.44 ± 8.378 |
| Clinical biochemistry tests (Mean ± SD) | - | |
| TSH (μIU/ml) | 1.79 ± 0.81 | |
| T4T (nmol/l) | 110.51 ± 12.35 | |
| T3T (nmol/l) | 2 ± 0.54 | |
| Lymph node metastasisa | - | |
| Negative | 26 | |
| Positive | 54 | |
| TNM stagesb | - | |
| I | 20 | |
| II | 52 | |
| III | 5 | |
| IVA | 3 |
PTC, papillary thyroid carcinoma.
a
Includes N1a and/or N1b.
b
American Joint Committee on Cancer (AJCC) Tumor-Node-Metastasis (TNM) staging system.